Penumbra, Inc. (PEN)
NYSE·Healthcare·Medical - Devices
$326.38
-0.49%
Mkt Cap $12.83B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $361.87M | $385.38M | +6.50% | $1.11 | $1.18 | +6.31% | — | — |
| Q4 2025 Nov 5, 2025 | $340.95M | $354.69M | +4.03% | $0.93 | $0.97 | +4.41% | — | — |
| Q3 2025 Jul 29, 2025 | $341.35M | $339.45M | -0.55% | $0.81 | $0.86 | +6.17% | — | — |
| Q2 2025 Apr 23, 2025 | $327.28M | $324.14M | -0.96% | $0.66 | $0.83 | +25.76% | — | — |
| Q1 2025 Feb 18, 2025 | $311.63M | $315.52M | +1.25% | $0.88 | $0.97 | +10.23% | — | — |
| Q4 2024 Oct 30, 2024 | $311.57M | $301.04M | -3.38% | $0.69 | $0.85 | +23.19% | — | — |
| Q3 2024 Jul 30, 2024 | $298.36M | $299.40M | +0.35% | $0.56 | $0.64 | +14.29% | — | — |
| Q2 2024 May 7, 2024 | $274.89M | $278.65M | +1.37% | $0.42 | $0.41 | -2.38% | — | — |
| Q1 2024 Feb 22, 2024 | $286.56M | $284.68M | -0.66% | $0.71 | $0.76 | +7.04% | — | — |
| Q4 2023 Nov 2, 2023 | $265.26M | $270.95M | +2.14% | $0.46 | $0.67 | +45.65% | — | — |
| Q3 2023 Aug 1, 2023 | $253.22M | $261.50M | +3.27% | $0.28 | $0.43 | +53.57% | — | — |
| Q2 2023 May 2, 2023 | $229.73M | $241.40M | +5.08% | $0.11 | $0.23 | +109.09% | — | — |
| Q1 2023 Feb 23, 2023 | $217.33M | $221.22M | +1.79% | $0.14 | $0.16 | +14.29% | — | — |
| Q4 2022 Nov 3, 2022 | $212.49M | $213.68M | +0.56% | $0.01 | $0.01 | +19.62% | — | — |
| Q3 2022 Aug 4, 2022 | $206.24M | $208.34M | +1.02% | -$0.07 | $0.01 | +114.29% | — | — |
| Q2 2022 May 3, 2022 | $195.39M | $203.90M | +4.35% | $0.06 | -$0.01 | -116.67% | — | — |
| Q1 2022 Feb 22, 2022 | $194.29M | $204.01M | +5.00% | $0.19 | $0.10 | -47.37% | — | — |
| Q4 2021 Nov 3, 2021 | $217.28M | $190.12M | -12.50% | $0.14 | $0.12 | -14.29% | — | — |
| Q3 2021 Aug 9, 2021 | $170.76M | $184.26M | +7.90% | $0.17 | $0.21 | +23.53% | — | — |
| Q2 2021 May 4, 2021 | $152.70M | $169.20M | +10.81% | $0.09 | $0.27 | +200.00% | — | — |